Request for Tender: Medicines Australia Continuing Education Program
Expression of Interest
Education Partner for the Medicines Australia Continuing Education Program
Medicines Australia, the peak body representing the innovative pharmaceutical industry in Australia, is seeking expressions of interest from suitably qualified education providers to deliver and support the ongoing development of its Continuing Education Program (CEP).
The CEP is a national professional education program that provides medical representatives, medical science liaison professionals and other pharmaceutical industry personnel with the knowledge, skills and ethical foundations required to perform their roles professionally and responsibly. The program supports high standards of ethical conduct, compliance and professional practice across the pharmaceutical industry.
The CEP is the only training program endorsed by Medicines Australia for this purpose. Completion of an endorsed Medicines Australia training program is mandatory for sales representatives, medical science liaison officers, and personnel directly involved in developing, reviewing or approving materials and educational activities directed to healthcare professionals or the general public.
The CEP comprises six core subjects covering the Medicines Australia Code of Conduct, the pharmaceutical and healthcare environment, human anatomy and physiology, introductory pharmacology, clinical evidence, and product information.
The CEP is a mature and established program with an existing curriculum, participant base and operating model. It supports approximately 1,000 learners annually (excluding bridging and update-only students). The program is delivered through an online learning model and represents an established industry standard for professional education within the Australian pharmaceutical sector.
As part of its periodic review of program delivery arrangements, Medicines Australia is seeking an education partner with demonstrated expertise in adult learning, online education, assessment, curriculum management and program delivery. Experience in healthcare education, professional accreditation, continuing professional development, regulated industries, learner support services and educational technology will be highly regarded.
The successful provider will work in partnership with Medicines Australia to support the ongoing management and continuous improvement of the program, including educational quality, assessment administration, learner experience, reporting and program governance.
Medicines Australia welcomes interest from universities, higher education providers and organisations with expertise in adult education, curriculum design, e-learning and professional training delivery.
The appointment is expected to be for an initial term of four years.
Organisations interested in participating in the forthcoming Request for Proposal (RFP) process are invited to register their interest with Medicines Australia. The RFP is expected to be released on 26 November 2026, with responses due by 1 February 2027.
Further information about the CEP is available here.
Enquiries and Expressions of Interest
Contact: Sophie Seck, Senior Manager, Ethics & Compliance
Email: cep@medicinesaustralia.com.au